These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20285456)

  • 41. [Determination of pepsin activity in gastric juice, serum and urine in patients with peptic ulcer].
    FUCIK M; RONSKY R; SKALA I
    Gastroenterologia; 1960; 93():79-86. PubMed ID: 13825538
    [No Abstract]   [Full Text] [Related]  

  • 42. [Calcium-phosphorus ratio in relapse of peptic ulcer disease].
    Fomina LA
    Eksp Klin Gastroenterol; 2011; (12):22-6. PubMed ID: 22629734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptic ulcer disease in childhood.
    SCHUSTER SR; GROSS RE
    Am J Surg; 1963 Mar; 105():324-33. PubMed ID: 13987318
    [No Abstract]   [Full Text] [Related]  

  • 44. Diagnosis and Treatment of Peptic Ulcer Disease.
    Kavitt RT; Lipowska AM; Anyane-Yeboa A; Gralnek IM
    Am J Med; 2019 Apr; 132(4):447-456. PubMed ID: 30611829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uropepsin and 17-hydroxycorticoid excretion in normal subjects and patients with peptic ulcer during both states of activity and quiescence.
    SLEISENGER MH; LEWIS CM; LIPKIN M; WIERUM C
    Am J Med; 1958 Sep; 25(3):395-400. PubMed ID: 13571253
    [No Abstract]   [Full Text] [Related]  

  • 46. The association of peptic ulcer and schizophrenia: a population-based study.
    Liao CH; Chang CS; Chang SN; Muo CH; Lane HY; Sung FC; Kao CH
    J Psychosom Res; 2014 Dec; 77(6):541-6. PubMed ID: 25199406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perceived stress as a risk factor for peptic ulcers: a register-based cohort study.
    Deding U; Ejlskov L; Grabas MP; Nielsen BJ; Torp-Pedersen C; Bøggild H
    BMC Gastroenterol; 2016 Nov; 16(1):140. PubMed ID: 27894275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uropepsin excretion studies in clinical surgery.
    LEVY AH; LEVINE S
    Gastroenterology; 1956 Feb; 30(2):270-8. PubMed ID: 13294315
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of gastroduodenal ulcers by administration of extracts of gastric or duodenal mucosa, or of urine].
    AUBERTIN E
    J Med Bord; 1951 Feb; 128(2):326-8. PubMed ID: 14814402
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacologic study of the anti-ulcer factor].
    MARAZZI E
    Farmaco Sci; 1955; 10(11):910-6. PubMed ID: 13294173
    [No Abstract]   [Full Text] [Related]  

  • 51. Epidemiology considerations in peptic ulcer disease.
    Schlesinger PK; Robinson B; Layden TJ
    J Assoc Acad Minor Phys; 1992; 3(3):70-7. PubMed ID: 1498525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs.
    Quan C; Talley NJ
    Am J Gastroenterol; 2002 Dec; 97(12):2950-61. PubMed ID: 12492176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of anti-secretory treatment in addition to Helicobacter pylori eradication triple therapy in the treatment of peptic ulcer].
    Jung JM; Shim KN; Oh HJ; Na YJ; Jung HS; Jung SA; Yoo K
    Korean J Gastroenterol; 2008 Jan; 51(1):11-8. PubMed ID: 18349557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The hereditary factor in peptic ulcer. The digestive ulcer, disease of recessive hereditary predisposition].
    DUBARRY JJ; PISOT C; DUHAMEL J
    Biol Med (Paris); 1960; 49():178-200. PubMed ID: 13818285
    [No Abstract]   [Full Text] [Related]  

  • 55. [Guidelines of prevention and treatment for NSAID-related peptic ulcers].
    Lee JH; Lee YC; Jeon SW; Kim JW; Lee SW; ;
    Korean J Gastroenterol; 2009 Nov; 54(5):309-17. PubMed ID: 19934612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Blood and urine prostaglandin E2 and prostaglandin F2 alpha in patients with chronic gastritis and peptic ulcer].
    Zhang SS; Jin JS; Zhao RL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Sep; 12(9):535-7, 517-8. PubMed ID: 1298470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
    Takemoto T; Yanai H
    Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
    [No Abstract]   [Full Text] [Related]  

  • 58. Peptic ulcer and non-steroidal anti-inflammatory agents.
    Duggan JM; Dobson AJ; Johnson H; Fahey P
    Gut; 1986 Aug; 27(8):929-33. PubMed ID: 3732900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls.
    Ching CK; Wong BC; Kwok E; Ong L; Covacci A; Lam SK
    Am J Gastroenterol; 1996 May; 91(5):949-53. PubMed ID: 8633586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [THE EXTERNAL SECRETORY FUNCTION OF THE PANCREAS IN PEPTIC ULCER].
    POZDNIAKOV VT
    Sov Med; 1963 May; 26():8-13. PubMed ID: 14073339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.